Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.
Novel enzymatic resolution route for high-purity Alzheimer's intermediate. Reduces cost and improves scalability for pharma manufacturing.
Patent CN103804225B details Pd-catalyzed coupling for Ivabradine intermediates. Offers scalable route with improved purity profiles for global pharmaceutical supply chains.
Patent CN102154377B reveals ScCR enzyme for asymmetric reduction. Enables cost-effective manufacturing of pharmaceutical intermediates with self-regenerating cofactors.
Novel deuteration method for Dasatinib improves metabolic stability. Offers high purity API intermediate for pharmaceutical supply chains.
Patent CN103483248A details a green synthesis for Pantoprazole intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN117510469A reveals high-yield route for dabigatran etexilate intermediate ensuring purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Advanced synthesis of 4-chloro-3-methoxy-2-methyl-4-pyridine via POCl3-DMF protocol. Reduces acidic waste and enhances yield for pantoprazole manufacturing supply chains.
Novel two-step synthesis improves yield and purity for curcumin derivatives. Reduces toxic solvent use and simplifies purification for reliable pharmaceutical intermediates supply chains.
Novel Suzuki coupling method for thienopyrimidine compounds. Enhances yield and scalability for pharmaceutical intermediate manufacturing supply chains.
Patent CN109134343B details a novel Pd-catalyzed route for 2-vinyl indoles, offering high yields and simplified processing for reliable pharmaceutical intermediate supply chains.
Novel patent CN117897146A enables high-purity methadone isomers with improved yield and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel pentamethine precursor method for high-purity NAD analogs. Scalable process reduces hazardous waste and ensures supply continuity for pharma intermediates.
Novel Suzuki coupling process for thienopyrimidine compounds enhances yield and scalability. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chains.
Patent CN114891838B reveals enzymatic resolution for dorzolamide intermediate. Achieve high purity and cost efficiency with scalable manufacturing processes.
Novel L-aspartic acid route for Sitagliptin phosphate synthesis. Cost-effective, high-purity manufacturing solution for global pharmaceutical supply chains.
Novel patent CN120229997A enables safer synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing processes globally.
Novel patent CN119080592A offers safer synthesis for Baloxavir intermediates with high purity and reduced environmental impact for supply chain stability.
Novel process for Aramchol using cholic acid. High optical purity, reduced steps. Ideal for API manufacturing cost reduction and supply chain stability.
Patent CN112638885B reveals a novel valsartan synthesis avoiding NDMA impurities. This method ensures high purity and supply chain reliability for global pharmaceutical manufacturers.